FormWeb • Example of Drug Shortage Information and Links

Resolved Shortages
Indocyanine green 25 mg injectable	Available
Drug Products on Critical Shortage
Drug Name	Details
colistin/HC/neomycin/thonzonium otic	Supply in pharmacy is depleted. Estimated: None
dronabinol capsules	Pharmacy has critical supply of 2.5 mg and limited supply of 5 mg capsules. Estimated release: None
epoetin alfa-epbx (Retacrit)	Supply of the various strengths in pharmacy ranges from good to depleted. Estimated release: periodic, with shortages expected to last through mid-2024.
methylprednisolone 2 mg tablets	Supply in pharmacy is depleted. Estimated release: Jun 2024. 4mg and 8mg tablets are readily available.
nalbuphine injectable	Supply in pharmacy is nearly depleted. Estimated release: Jun 2024.
Rho(D) immune globulin	Supply in pharmacy is critical. Estimated release: periodic and unpredictable throughout 2024.
Drug Products on Shortage - Limited Availability
Drug Name	Details
acyclovir injectable 500 mg	Supply in pharmacy is critical. Estimate release is May 2024
dextrose 50% injectable	Pharmacy has critical supply of vials and manufacturer syringes. Estimated release: Jul 2024 for vials & syringes.
diphenoxylate/atropine oral liquid	Supply of the oral liquid is critical in pharmacy; tablets are available. Estimated release: none
etoposide injectable	Supply in pharmacy is critical. Estimated release: Jun 2024.
hydrocodone/APAP oral solution	Supply in pharmacy is limited. Estimated release: none
isosorbide mononitrate tablets	Estimated release: 10mg, none; 20mg, May 2024
rifaximin 200 mg tablets	Supply in pharmacy is nearly depleted. Estimated release: none
sodium bicarbonate injectable	Supply of 50 mL syringes is critical in pharmacy. 10ml syringes will expire this month. Vial supply of both sizes is reasonable. Estimated release: Jul 2024 (syringes), Jul 2024 (vials).
Relevant Products on National Shortage – No Practice Changes Needed
Drug Name	Details
cyclopentolate 1% and 2% ophthalmic	Pharmacy has adequate supply to meet needs.
diazepam 5 mg/mL-2 mL injection	Pharmacy has adequate supply to meet needs.
penicillin G benzathine injectable	Pharmacy has adequate supply to meet needs.
sodium acetate injectable	Pharmacy has adequate supply to meet needs.
Discontinued (no longer being manufactured)
Drug Name	Notes/Information
activated charcoal pellets	Supply in pharmacy is critical. All pellet charcoal products have been discontinued.
lindane products	All presentations have been discontinued FDA Orange Book
mafenide acetate powder for solution	Ingenus has discontinued mafenide powder for topical solution. Mylan has discontinued Sulfamylon powder for topical solution. Sulfamylon powder for solution was initially approved under the FDA accelerated approval program. The product's continued approval required a confirmatory study, which was not performed. Consequently, the product is no longer FDA approved. Par has discontinued mafenide powder for topical solution.
methyldopa tablet	Accord has discontinued methyldopa. Mylan discontinued the unit-dose presentations in 2019. They discontinued the 100 count bottles in June 2021. Teva discontinued methyldopa tablets in 2018.
nicotine inhalation system	Pfizer discontinued Nicotrol inhaler in the first half of 2023. The product was discontinued due to unavailability of an essential resin used to produce the inhaler mouthpiece. Additional information can be found at https://cdn.pfizer.com/pfizercom/DHCP_Letter_Nicotrol_Inhaler_5.30.2023.pdf. Nicotine nasal spray continues to be available.
testosterone transdermal patches	Allergan (Abbvie) has discontinued Androderm transdermal patches. Allergan (Abbvie) was the sole supplier of testosterone transdermal patches.

For further information regarding Formweb
please call 800.467.1907.